 | • レポートコード：QAF27093 • 出版社/出版日：QYResearch / 2021年4月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の皮膚充填剤＆ボツリヌストキシン市場について種類別（皮膚充填剤、ボツリヌストキシン）、用途別（医療、化粧品）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・皮膚充填剤＆ボツリヌストキシン市場の概要 ・世界の主要地域別皮膚充填剤＆ボツリヌストキシン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の皮膚充填剤＆ボツリヌストキシン市場規模2016-2021：種類別（皮膚充填剤、ボツリヌストキシン） ・世界の皮膚充填剤＆ボツリヌストキシン市場予測2012-2027：種類別（皮膚充填剤、ボツリヌストキシン） ・世界の皮膚充填剤＆ボツリヌストキシン市場規模2016-2021：用途別（医療、化粧品） ・世界の皮膚充填剤＆ボツリヌストキシン市場予測2012-2027：用途別（医療、化粧品） ・皮膚充填剤＆ボツリヌストキシンのアメリカ市場規模と予測2016-2021 ・皮膚充填剤＆ボツリヌストキシンのヨーロッパ市場規模と予測2016-2021 ・皮膚充填剤＆ボツリヌストキシンの中国市場規模と予測2016-2021 ・皮膚充填剤＆ボツリヌストキシンの日本市場規模と予測2016-2021 ・皮膚充填剤＆ボツリヌストキシンの東南アジア市場規模と予測2016-2021 ・皮膚充填剤＆ボツリヌストキシンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Allergan、Galderma、LG Life Science、Merz、Medytox、Bloomage、Bohus BioTech、Sinclair Pharma、IMEIK、Suneva Medical、Teoxane、Luminera、SciVision Biotech、Haohai Bio、Ipsen、LIBP、US World Meds、Hugel、Daewoong） ・皮膚充填剤＆ボツリヌストキシンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・皮膚充填剤＆ボツリヌストキシンの市場動向・機会・課題 ・調査の結論 |
Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism.
Market competition is intense. Allergan, Galderma, LG Life Science, Ipsen, Merz, etc. are the leaders of the industry. Allergan hold the largest market share of 58.7% in 2019.
Market Analysis and Insights: Global Dermal Fillers and Botulinum Toxin Market
The global Dermal Fillers and Botulinum Toxin market was valued at US$ 12050 in 2020 and will reach US$ 26720 million by the end of 2027, growing at a CAGR of 14.2% during 2022-2027.
Global Dermal Fillers and Botulinum Toxin Scope and Market Size
The global Dermal Fillers and Botulinum Toxin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermal Fillers and Botulinum Toxin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Dermal Fillers
Botulinum Toxin
The proportion of dermal fillers in 2019 is about 52%.
Segment by Application
Medical
Cosmetic
The most of dermal fillers and botulinum toxin is used in cosmetic, and the market share of that is about 75.5% in 2019.
The Dermal Fillers and Botulinum Toxin market is analysed and market size information is provided by regions (countries). Segment by Application, the Dermal Fillers and Botulinum Toxin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Allergan
Galderma
LG Life Science
Merz
Medytox
Bloomage
Bohus BioTech
Sinclair Pharma
IMEIK
Suneva Medical
Teoxane
Luminera
SciVision Biotech
Haohai Bio
Ipsen
LIBP
US World Meds
Hugel
Daewoong
1 Dermal Fillers and Botulinum Toxin Market Overview
1.1 Dermal Fillers and Botulinum Toxin Product Scope
1.2 Dermal Fillers and Botulinum Toxin Segment by Type
1.2.1 Global Dermal Fillers and Botulinum Toxin Sales by Type (2016 & 2021 & 2027)
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.3 Dermal Fillers and Botulinum Toxin Segment by Application
1.3.1 Global Dermal Fillers and Botulinum Toxin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Medical
1.3.3 Cosmetic
1.4 Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Dermal Fillers and Botulinum Toxin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Dermal Fillers and Botulinum Toxin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Dermal Fillers and Botulinum Toxin Price Trends (2016-2027)
2 Dermal Fillers and Botulinum Toxin Estimates and Forecasts by Region
2.1 Global Dermal Fillers and Botulinum Toxin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Dermal Fillers and Botulinum Toxin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
2.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2016-2021)
2.3 Global Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Dermal Fillers and Botulinum Toxin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Dermal Fillers and Botulinum Toxin Estimates and Projections (2016-2027)
2.4.2 Europe Dermal Fillers and Botulinum Toxin Estimates and Projections (2016-2027)
2.4.3 China Dermal Fillers and Botulinum Toxin Estimates and Projections (2016-2027)
2.4.4 Japan Dermal Fillers and Botulinum Toxin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Dermal Fillers and Botulinum Toxin Estimates and Projections (2016-2027)
2.4.6 India Dermal Fillers and Botulinum Toxin Estimates and Projections (2016-2027)
3 Global Dermal Fillers and Botulinum Toxin Competition Landscape by Players
3.1 Global Top Dermal Fillers and Botulinum Toxin Players by Sales (2016-2021)
3.2 Global Top Dermal Fillers and Botulinum Toxin Players by Revenue (2016-2021)
3.3 Global Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2020)
3.4 Global Dermal Fillers and Botulinum Toxin Average Price by Company (2016-2021)
3.5 Manufacturers Dermal Fillers and Botulinum Toxin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Dermal Fillers and Botulinum Toxin Market Size by Type
4.1 Global Dermal Fillers and Botulinum Toxin Historic Market Review by Type (2016-2021)
4.1.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
4.1.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2016-2021)
4.1.3 Global Dermal Fillers and Botulinum Toxin Price by Type (2016-2021)
4.2 Global Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2022-2027)
4.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2022-2027)
4.2.3 Global Dermal Fillers and Botulinum Toxin Price Forecast by Type (2022-2027)
5 Global Dermal Fillers and Botulinum Toxin Market Size by Application
5.1 Global Dermal Fillers and Botulinum Toxin Historic Market Review by Application (2016-2021)
5.1.1 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
5.1.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2016-2021)
5.1.3 Global Dermal Fillers and Botulinum Toxin Price by Application (2016-2021)
5.2 Global Dermal Fillers and Botulinum Toxin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2022-2027)
5.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2022-2027)
5.2.3 Global Dermal Fillers and Botulinum Toxin Price Forecast by Application (2022-2027)
6 North America Dermal Fillers and Botulinum Toxin Market Facts & Figures
6.1 North America Dermal Fillers and Botulinum Toxin Sales by Company
6.1.1 North America Dermal Fillers and Botulinum Toxin Sales by Company (2016-2021)
6.1.2 North America Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021)
6.2 North America Dermal Fillers and Botulinum Toxin Sales Breakdown by Type
6.2.1 North America Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2016-2021)
6.2.2 North America Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2022-2027)
6.3 North America Dermal Fillers and Botulinum Toxin Sales Breakdown by Application
6.3.1 North America Dermal Fillers and Botulinum Toxin Sales Breakdown by Application (2016-2021)
6.3.2 North America Dermal Fillers and Botulinum Toxin Sales Breakdown by Application (2022-2027)
7 Europe Dermal Fillers and Botulinum Toxin Market Facts & Figures
7.1 Europe Dermal Fillers and Botulinum Toxin Sales by Company
7.1.1 Europe Dermal Fillers and Botulinum Toxin Sales by Company (2016-2021)
7.1.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021)
7.2 Europe Dermal Fillers and Botulinum Toxin Sales Breakdown by Type
7.2.1 Europe Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2022-2027)
7.3 Europe Dermal Fillers and Botulinum Toxin Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Dermal Fillers and Botulinum Toxin Market Facts & Figures
8.1 China Dermal Fillers and Botulinum Toxin Sales by Company
8.1.1 China Dermal Fillers and Botulinum Toxin Sales by Company (2016-2021)
8.1.2 China Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021)
8.2 China Dermal Fillers and Botulinum Toxin Sales Breakdown by Type
8.2.1 China Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2016-2021)
8.2.2 China Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2022-2027)
8.3 China Dermal Fillers and Botulinum Toxin Sales Breakdown by Application
8.3.1 China 310 Sales Breakdown by Application (2016-2021)
8.3.2 China 310 Sales Breakdown by Application (2022-2027)
9 Japan Dermal Fillers and Botulinum Toxin Market Facts & Figures
9.1 Japan Dermal Fillers and Botulinum Toxin Sales by Company
9.1.1 Japan Dermal Fillers and Botulinum Toxin Sales by Company (2016-2021)
9.1.2 Japan Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021)
9.2 Japan Dermal Fillers and Botulinum Toxin Sales Breakdown by Type
9.2.1 Japan Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2022-2027)
9.3 Japan Dermal Fillers and Botulinum Toxin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Dermal Fillers and Botulinum Toxin Market Facts & Figures
10.1 Southeast Asia Dermal Fillers and Botulinum Toxin Sales by Company
10.1.1 Southeast Asia Dermal Fillers and Botulinum Toxin Sales by Company (2016-2021)
10.1.2 Southeast Asia Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021)
10.2 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Breakdown by Type
10.2.1 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Dermal Fillers and Botulinum Toxin Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Dermal Fillers and Botulinum Toxin Market Facts & Figures
11.1 India Dermal Fillers and Botulinum Toxin Sales by Company
11.1.1 India Dermal Fillers and Botulinum Toxin Sales by Company (2016-2021)
11.1.2 India Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021)
11.2 India Dermal Fillers and Botulinum Toxin Sales Breakdown by Type
11.2.1 India Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2016-2021)
11.2.2 India Dermal Fillers and Botulinum Toxin Sales Breakdown by Type (2022-2027)
11.3 India Dermal Fillers and Botulinum Toxin Sales Breakdown by Application
11.3.1 India Dermal Fillers and Botulinum Toxin Sales Breakdown by Application (2016-2021)
11.3.2 India Dermal Fillers and Botulinum Toxin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Dermal Fillers and Botulinum Toxin Business
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Business Overview
12.1.3 Allergan Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Dermal Fillers and Botulinum Toxin Products Offered
12.1.5 Allergan Recent Development
12.2 Galderma
12.2.1 Galderma Corporation Information
12.2.2 Galderma Business Overview
12.2.3 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Galderma Dermal Fillers and Botulinum Toxin Products Offered
12.2.5 Galderma Recent Development
12.3 LG Life Science
12.3.1 LG Life Science Corporation Information
12.3.2 LG Life Science Business Overview
12.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 LG Life Science Dermal Fillers and Botulinum Toxin Products Offered
12.3.5 LG Life Science Recent Development
12.4 Merz
12.4.1 Merz Corporation Information
12.4.2 Merz Business Overview
12.4.3 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merz Dermal Fillers and Botulinum Toxin Products Offered
12.4.5 Merz Recent Development
12.5 Medytox
12.5.1 Medytox Corporation Information
12.5.2 Medytox Business Overview
12.5.3 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Medytox Dermal Fillers and Botulinum Toxin Products Offered
12.5.5 Medytox Recent Development
12.6 Bloomage
12.6.1 Bloomage Corporation Information
12.6.2 Bloomage Business Overview
12.6.3 Bloomage Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bloomage Dermal Fillers and Botulinum Toxin Products Offered
12.6.5 Bloomage Recent Development
12.7 Bohus BioTech
12.7.1 Bohus BioTech Corporation Information
12.7.2 Bohus BioTech Business Overview
12.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Products Offered
12.7.5 Bohus BioTech Recent Development
12.8 Sinclair Pharma
12.8.1 Sinclair Pharma Corporation Information
12.8.2 Sinclair Pharma Business Overview
12.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sinclair Pharma Dermal Fillers and Botulinum Toxin Products Offered
12.8.5 Sinclair Pharma Recent Development
12.9 IMEIK
12.9.1 IMEIK Corporation Information
12.9.2 IMEIK Business Overview
12.9.3 IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 IMEIK Dermal Fillers and Botulinum Toxin Products Offered
12.9.5 IMEIK Recent Development
12.10 Suneva Medical
12.10.1 Suneva Medical Corporation Information
12.10.2 Suneva Medical Business Overview
12.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Suneva Medical Dermal Fillers and Botulinum Toxin Products Offered
12.10.5 Suneva Medical Recent Development
12.11 Teoxane
12.11.1 Teoxane Corporation Information
12.11.2 Teoxane Business Overview
12.11.3 Teoxane Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teoxane Dermal Fillers and Botulinum Toxin Products Offered
12.11.5 Teoxane Recent Development
12.12 Luminera
12.12.1 Luminera Corporation Information
12.12.2 Luminera Business Overview
12.12.3 Luminera Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Luminera Dermal Fillers and Botulinum Toxin Products Offered
12.12.5 Luminera Recent Development
12.13 SciVision Biotech
12.13.1 SciVision Biotech Corporation Information
12.13.2 SciVision Biotech Business Overview
12.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 SciVision Biotech Dermal Fillers and Botulinum Toxin Products Offered
12.13.5 SciVision Biotech Recent Development
12.14 Haohai Bio
12.14.1 Haohai Bio Corporation Information
12.14.2 Haohai Bio Business Overview
12.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Haohai Bio Dermal Fillers and Botulinum Toxin Products Offered
12.14.5 Haohai Bio Recent Development
12.15 Ipsen
12.15.1 Ipsen Corporation Information
12.15.2 Ipsen Business Overview
12.15.3 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Ipsen Dermal Fillers and Botulinum Toxin Products Offered
12.15.5 Ipsen Recent Development
12.16 LIBP
12.16.1 LIBP Corporation Information
12.16.2 LIBP Business Overview
12.16.3 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.16.4 LIBP Dermal Fillers and Botulinum Toxin Products Offered
12.16.5 LIBP Recent Development
12.17 US World Meds
12.17.1 US World Meds Corporation Information
12.17.2 US World Meds Business Overview
12.17.3 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.17.4 US World Meds Dermal Fillers and Botulinum Toxin Products Offered
12.17.5 US World Meds Recent Development
12.18 Hugel
12.18.1 Hugel Corporation Information
12.18.2 Hugel Business Overview
12.18.3 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Hugel Dermal Fillers and Botulinum Toxin Products Offered
12.18.5 Hugel Recent Development
12.19 Daewoong
12.19.1 Daewoong Corporation Information
12.19.2 Daewoong Business Overview
12.19.3 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Daewoong Dermal Fillers and Botulinum Toxin Products Offered
12.19.5 Daewoong Recent Development
13 Dermal Fillers and Botulinum Toxin Manufacturing Cost Analysis
13.1 Dermal Fillers and Botulinum Toxin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
13.4 Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dermal Fillers and Botulinum Toxin Distributors List
14.3 Dermal Fillers and Botulinum Toxin Customers
15 Market Dynamics
15.1 Dermal Fillers and Botulinum Toxin Market Trends
15.2 Dermal Fillers and Botulinum Toxin Drivers
15.3 Dermal Fillers and Botulinum Toxin Market Challenges
15.4 Dermal Fillers and Botulinum Toxin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dermal Fillers and Botulinum Toxin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Dermal Fillers and Botulinum Toxin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Dermal Fillers and Botulinum Toxin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Region (2016-2021)
Table 5. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2016-2021)
Table 6. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Dermal Fillers and Botulinum Toxin Revenue Share by Region (2016-2021)
Table 8. Global Dermal Fillers and Botulinum Toxin Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Dermal Fillers and Botulinum Toxin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Dermal Fillers and Botulinum Toxin Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Dermal Fillers and Botulinum Toxin Sales Share by Company (2016-2021)
Table 14. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Dermal Fillers and Botulinum Toxin Revenue Share by Company (2016-2021)
Table 16. Global Dermal Fillers and Botulinum Toxin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2020)
Table 17. Global Dermal Fillers and Botulinum Toxin Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Dermal Fillers and Botulinum Toxin Manufacturing Sites and Area Served
Table 19. Manufacturers Dermal Fillers and Botulinum Toxin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Type (2016-2021)
Table 22. Global Dermal Fillers and Botulinum Toxin Sales Share by Type (2016-2021)
Table 23. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Type (2016-2021)
Table 25. Global Dermal Fillers and Botulinum Toxin Sales Share by Type (2022-2027)
Table 26. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Dermal Fillers and Botulinum Toxin Revenue Share by Type (2022-2027)
Table 28. Global Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Type (2022-2027)
Table 29. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2016-2021)
Table 30. Global Dermal Fillers and Botulinum Toxin Sales Share by Application (2016-2021)
Table 31. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Application (2016-2021)
Table 33. Global Dermal Fillers and Botulinum Toxin Sales (K Units) by Application (2022-2027)
Table 34. Global Dermal Fillers and Botulinum Toxin Sales Share by Application (2022-2027)
Table 35. Global Dermal Fillers and Botulinum Toxin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Dermal Fillers and Botulinum Toxin Revenue Share by Application (2022-2027)
Table 37. Global Dermal Fillers and Botulinum Toxin Price (US$/Unit) by Application (2022-2027)
Table 38. North America Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2016-2021)
Table 39. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2016-2021)
Table 40. North America Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2016-2021)
Table 42. North America Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 43. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 44. North America Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 45. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2022-2027)
Table 46. North America Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 47. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 48. North America Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 49. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2022-2027)
Table 50. Europe Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2016-2021)
Table 51. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2016-2021)
Table 52. Europe Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2016-2021)
Table 54. Europe Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 55. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 56. Europe Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 57. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2022-2027)
Table 58. Europe Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 59. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 60. Europe Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 61. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2022-2027)
Table 62. China Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2016-2021)
Table 63. China Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2016-2021)
Table 64. China Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2016-2021)
Table 66. China Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 67. China Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 68. China Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 69. China Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2022-2027)
Table 70. China Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 71. China Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 72. China Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 73. China Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2022-2027)
Table 74. Japan Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2016-2021)
Table 75. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2016-2021)
Table 76. Japan Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2016-2021)
Table 78. Japan Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 79. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 80. Japan Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 81. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2022-2027)
Table 82. Japan Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 83. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 84. Japan Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 85. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2022-2027)
Table 98. India Dermal Fillers and Botulinum Toxin Sales (K Units) by Company (2016-2021)
Table 99. India Dermal Fillers and Botulinum Toxin Sales Market Share by Company (2016-2021)
Table 100. India Dermal Fillers and Botulinum Toxin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Dermal Fillers and Botulinum Toxin Revenue Market Share by Company (2016-2021)
Table 102. India Dermal Fillers and Botulinum Toxin Sales by Type (2016-2021) & (K Units)
Table 103. India Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2016-2021)
Table 104. India Dermal Fillers and Botulinum Toxin Sales by Type (2022-2027) & (K Units)
Table 105. India Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2022-2027)
Table 106. India Dermal Fillers and Botulinum Toxin Sales by Application (2016-2021) & (K Units)
Table 107. India Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2016-2021)
Table 108. India Dermal Fillers and Botulinum Toxin Sales by Application (2022-2027) & (K Units)
Table 109. India Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2022-2027)
Table 110. Allergan Corporation Information
Table 111. Allergan Description and Business Overview
Table 112. Allergan Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Allergan Dermal Fillers and Botulinum Toxin Product
Table 114. Allergan Recent Development
Table 115. Galderma Corporation Information
Table 116. Galderma Description and Business Overview
Table 117. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Galderma Dermal Fillers and Botulinum Toxin Product
Table 119. Galderma Recent Development
Table 120. LG Life Science Corporation Information
Table 121. LG Life Science Description and Business Overview
Table 122. LG Life Science Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. LG Life Science Dermal Fillers and Botulinum Toxin Product
Table 124. LG Life Science Recent Development
Table 125. Merz Corporation Information
Table 126. Merz Description and Business Overview
Table 127. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Merz Dermal Fillers and Botulinum Toxin Product
Table 129. Merz Recent Development
Table 130. Medytox Corporation Information
Table 131. Medytox Description and Business Overview
Table 132. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Medytox Dermal Fillers and Botulinum Toxin Product
Table 134. Medytox Recent Development
Table 135. Bloomage Corporation Information
Table 136. Bloomage Description and Business Overview
Table 137. Bloomage Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Bloomage Dermal Fillers and Botulinum Toxin Product
Table 139. Bloomage Recent Development
Table 140. Bohus BioTech Corporation Information
Table 141. Bohus BioTech Description and Business Overview
Table 142. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Bohus BioTech Dermal Fillers and Botulinum Toxin Product
Table 144. Bohus BioTech Recent Development
Table 145. Sinclair Pharma Corporation Information
Table 146. Sinclair Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Sinclair Pharma Description and Business Overview
Table 148. Sinclair Pharma Dermal Fillers and Botulinum Toxin Product
Table 149. Sinclair Pharma Recent Development
Table 150. IMEIK Corporation Information
Table 151. IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. IMEIK Description and Business Overview
Table 153. IMEIK Dermal Fillers and Botulinum Toxin Product
Table 154. IMEIK Recent Development
Table 155. Suneva Medical Corporation Information
Table 156. Suneva Medical Description and Business Overview
Table 157. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Suneva Medical Dermal Fillers and Botulinum Toxin Product
Table 159. Suneva Medical Recent Development
Table 160. Teoxane Corporation Information
Table 161. Teoxane Description and Business Overview
Table 162. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Teoxane Dermal Fillers and Botulinum Toxin Product
Table 164. Teoxane Recent Development
Table 165. Luminera Corporation Information
Table 166. Luminera Description and Business Overview
Table 167. Luminera Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Luminera Dermal Fillers and Botulinum Toxin Product
Table 169. Luminera Recent Development
Table 170. SciVision Biotech Corporation Information
Table 171. SciVision Biotech Description and Business Overview
Table 172. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 173. SciVision Biotech Dermal Fillers and Botulinum Toxin Product
Table 174. SciVision Biotech Recent Development
Table 175. Haohai Bio Corporation Information
Table 176. Haohai Bio Description and Business Overview
Table 177. Haohai Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 178. Haohai Bio Dermal Fillers and Botulinum Toxin Product
Table 179. Haohai Bio Recent Development
Table 180. Ipsen Corporation Information
Table 181. Ipsen Description and Business Overview
Table 182. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 183. Ipsen Dermal Fillers and Botulinum Toxin Product
Table 184. Ipsen Recent Development
Table 185. LIBP Corporation Information
Table 186. LIBP Description and Business Overview
Table 187. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 188. LIBP Dermal Fillers and Botulinum Toxin Product
Table 189. LIBP Recent Development
Table 190. US World Meds Corporation Information
Table 191. US World Meds Description and Business Overview
Table 192. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 193. US World Meds Dermal Fillers and Botulinum Toxin Product
Table 194. US World Meds Recent Development
Table 195. Hugel Corporation Information
Table 196. Hugel Description and Business Overview
Table 197. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 198. Hugel Dermal Fillers and Botulinum Toxin Product
Table 199. Hugel Recent Development
Table 200. Daewoong Corporation Information
Table 201. Daewoong Description and Business Overview
Table 202. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 203. Daewoong Dermal Fillers and Botulinum Toxin Product
Table 204. Daewoong Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Dermal Fillers and Botulinum Toxin Distributors List
Table 208. Dermal Fillers and Botulinum Toxin Customers List
Table 209. Dermal Fillers and Botulinum Toxin Market Trends
Table 210. Dermal Fillers and Botulinum Toxin Market Drivers
Table 211. Dermal Fillers and Botulinum Toxin Market Challenges
Table 212. Dermal Fillers and Botulinum Toxin Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermal Fillers and Botulinum Toxin Product Picture
Figure 2. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2021 & 2027
Figure 6. Medical Examples
Figure 7. Cosmetic Examples
Figure 8. Global Dermal Fillers and Botulinum Toxin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Dermal Fillers and Botulinum Toxin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Dermal Fillers and Botulinum Toxin Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Dermal Fillers and Botulinum Toxin Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 12. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Dermal Fillers and Botulinum Toxin Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Dermal Fillers and Botulinum Toxin Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Dermal Fillers and Botulinum Toxin Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Dermal Fillers and Botulinum Toxin Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Dermal Fillers and Botulinum Toxin Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Dermal Fillers and Botulinum Toxin Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Dermal Fillers and Botulinum Toxin Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Dermal Fillers and Botulinum Toxin Players Market Share by Revenue in Dermal Fillers and Botulinum Toxin: 2016 & 2020
Figure 27. Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Dermal Fillers and Botulinum Toxin Revenue Share by Type (2016-2021)
Figure 29. Global Dermal Fillers and Botulinum Toxin Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Dermal Fillers and Botulinum Toxin Revenue Share by Application (2016-2021)
Figure 31. Global Dermal Fillers and Botulinum Toxin Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 33. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 34. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 35. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 36. China Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 37. China Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 38. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 39. Japan Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 40. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 41. Southeast Asia Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 42. India Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2020
Figure 43. India Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Dermal Fillers and Botulinum Toxin
Figure 46. Manufacturing Process Analysis of Dermal Fillers and Botulinum Toxin
Figure 47. Dermal Fillers and Botulinum Toxin Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
ボツリヌス毒素フィラーのグローバル市場調査 2019年 The global Botulinum Toxin Fillers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Botulinum Toxin Fillers volume and value at global level, regional level and company level. From a global perspecti…- ヒアルロン酸系ダーマフィラーのグローバル市場2021 Hyaluronic Acid Based Dermal Fillers are the product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, and adding facial volume and contour. Global production of Hyaluronic Acid Based Dermal Fillers was about 11731.49 k units in 2015, and will reach to 12795…
- 世界の皮膚同種移植市場規模・現状・予測（2021年-2027年） Dermal Allograft is a technique used to treat and improve the damaged inner layer of skin called dermis. The dermal allograft is done from one person to another of similar species but with a different genotype. The dermal allograft is developed from human tissue or synthetic tissue or combinations o…
- 世界の無細胞真皮マトリックス市場規模・現状・予測（2021年-2027年） Acellular dermal matrix is a biologically derived product, which is devoid of cells. The main components of acellular dermal matrix include collagen and elastic fibers. It has applications in plastic surgery, general surgery, breast reconstruction, cosmetic surgery, wound healing, and others. The ma…
- 世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年） Clostridium botulinum infections are caused by clostridium botulinum, a gram-positive, rod-shaped bacterium which produces an extremely lethal substance that is botulism neurotoxin. Market Analysis and Insights: Global Clostridium Botulinum Infection Treatment Market The global Clostridium Botulinum…